You do realise that MSB always price-sensitively announce first patient enrolments as well right? It's a biotech thing and irrespective of when first revenues are anticipated. IMU also doing so today. I'm surprised you're not better informed given how heavily invested you are said to be in the sector.
Ann: First Patient enrolled - SynPath Diabetic Foot Ulcer Trial, page-21
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.25 |
Change
0.050(2.27%) |
Mkt cap ! $1.553B | |||
| Open | High | Low | Value | Volume |
| $2.24 | $2.25 | $2.17 | $3.964M | 1.773M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 22141 | $2.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.25 | 17044 | 4 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.24 |
Change
0.050 ( 2.25 %) |
||||
| Open | High | Low | Volume | ||
| $2.24 | $2.25 | $2.17 | 278730 | ||
| Last updated 15.59pm 31/05/2024 ? | |||||
| PNV (ASX) Chart |